ADC Therapeutics

Layoffs
Pharma

ADC plots 17% staff cuts amid Zynlonta safety concerns

After a recent safety scare in a confirmatory trial of Zynlonta, ADC Therapeutics is tightening its belt.
Fraiser Kansteiner Jun 24, 2026 10:19am
Zynlonta

Patient deaths raise questions about ADC's cancer drug Zynlonta

Jun 4, 2026 11:38am
Close-up of excavator at construction site

CDMO Axplora to pump $60M into Italian complex API plant

Mar 19, 2026 8:50am
A series of dice with a bag on them illustrating cost cuts
Favicon Fierce Biotech

ADC Therapeutics shutters UK R&D site, lays off 30% of staff

Jun 12, 2025 3:00pm
Merck KGaA MilliporeSigma US

MilliporeSigma's production push rolls with $76M ADC investment

Oct 29, 2024 10:33am
NandiniPiramal

Piramal to pump $80M into expansion of Kentucky injectables site

Oct 1, 2024 8:12am